Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma

Lodde, Georg C.; Hassel, Jessica C.; von Wasielewski, Imke; Meier, Friedegund; Mohr, Peter; Kahler, Katharina; Hauschild, Axel; Glutsch, Valerie; Stege, Henner; Berking, Carola; Huning, Svea; Huynh, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Schilling, Bastian; Loquai, Carmen; Erdmann, Michael; Stang, Andreas; Kowall, Bernd; Galetzka, Wolfgang; Roesch, Alexander; Tilkorn, Daniel; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Forschner, Andrea; Livingstone, Elisabeth

Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma

Autor(en):

Lodde, Georg C.; Hassel, Jessica C.; von Wasielewski, Imke; Meier, Friedegund; Mohr, Peter; Kahler, Katharina; Hauschild, Axel; Glutsch, Valerie; Stege, Henner; Berking, Carola; Huning, Svea; Huynh, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Schilling, Bastian; Loquai, Carmen; Erdmann, Michael; Stang, Andreas; Kowall, Bernd; Galetzka, Wolfgang; Roesch, Alexander; Tilkorn, Daniel; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Forschner, Andrea; Livingstone, Elisabeth

Tübinger Autor(en):

Huynh, Julia
Forschner, Andrea Lydia

Erschienen in:

Journal of Clinical Oncology (2025), Bd. 43, H. 25, S. 2793-2805

Verlagsangabe:

Alexandria, Va. : American Society of Clinical Oncology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO-24-02776

ISSN:

0732-183X